A comprehensive view of biontech se. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
US Patent Issued to GENMAB, BioNTech on March 26 for "Multispecific antibodies against CD40 and CD137" (Dutch, German Inventors)
Published:
March 27, 2024
by U.S. Fed News
|
BioNTech receives a notice of default from the NIH over allegedly owed vaccine royalties under a prior licensing agreement
Published:
March 25, 2024
by FiercePharma
|
INTERNATIONAL PATENT: BIONTECH SE, TRON - TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITATSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITAT MAINZ GEMEINNUTZIGE GMBH FILES APPLICATION FOR "SYSTEMS AND COMPOSITIONS COMPRISING TRANS-AMPLIFYING RNA VECTORS WITH MIRNA"
Published:
March 25, 2024
by U.S. Fed News
|
BioNTech reports Q4 net profit of US$497.0M, Q4 revenue of US$1.6B; full-year net income drops 90% year-over-year to US$1.0B, revenue down 90% YoY to US$4.14B
Published:
March 20, 2024
by Benzinga Lightning Feed
|
BioNTech announces fourth quarter and full year 2023 financial results and corporate update
Published:
March 20, 2024
by BioNTech SE
|
Ask us about our Health Care Sector market view